Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.12116 | 6 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.09874 | 6 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.10175 | 6 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.05173 | 5 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.04234 | 5 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.14687 | 6 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.09497 | 5 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.0805 | 6 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.06552 | 5 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.08933 | 6 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.08234 | 6 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.07412 | 6 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.09249 | 6 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.08821 | 6 |